Cargando…

Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence

Prothrombotic fibrin clot phenotype, involving faster formation of dense meshwork composed of thinner and highly branched fibers that are relatively resistant to plasmin-induced lysis, has been reported in patients with not only myocardial infarction or stroke, but also venous thromboembolism (VTE),...

Descripción completa

Detalles Bibliográficos
Autor principal:	Undas, Anetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504927/ https://www.ncbi.nlm.nih.gov/pubmed/28740853 http://dx.doi.org/10.1155/2017/8196256

Ejemplares similares

Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype
por: Natorska, Joanna, et al.
Publicado: (2023)

Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study
por: Polak, Maciej Wiktor, et al.
Publicado: (2019)

P1699: ANTITHROMBIN DEFICIENCY IS ASSOCIATED WITH PROTHROMBOTIC FIBRIN CLOT PHENOTYPE
por: Zabczyk, M., et al.
Publicado: (2022)

Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)

Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism
por: Kupis, Robert W., et al.
Publicado: (2019)

Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia
por: Nowakowski, Tomasz, et al.
Publicado: (2019)

Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties
por: Skuza, Anna Aleksandra, et al.
Publicado: (2018)

Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
por: Bochenek, Maciej, et al.
Publicado: (2012)

Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception
por: Piróg, Magdalena, et al.
Publicado: (2019)

Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein
por: Szułdrzyński, Konstanty, et al.
Publicado: (2020)

Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk
por: Gajos, Grzegorz, et al.
Publicado: (2015)

Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
por: Undas, Anetta, et al.
Publicado: (2008)

Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis
por: Sobczak, Amélie I. S., et al.
Publicado: (2020)

Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2018)

Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016)

Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study
por: Bryk, Agata Hanna, et al.
Publicado: (2021)

Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency
por: Bezuidenhout, Johannes A., et al.
Publicado: (2020)

Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism
por: Kim, Samuel H, et al.
Publicado: (2018)

Silent Pulmonary Embolism in Deep Vein Thrombosis: Relationship and Risk Factors
por: Shi, Yadong, et al.
Publicado: (2022)

Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia
por: Mastalerz, Lucyna, et al.
Publicado: (2015)

Iron Deficiency Anemia as a Rare Risk Factor for Recurrent Pulmonary Embolism and Deep Vein Thrombosis
por: Ezeh, Ebubechukwu, et al.
Publicado: (2021)

Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016)

Deep Vein Thrombosis and Pulmonary Embolism in the Setting of Mycoplasma Infection
por: Saleem, Sandal, et al.
Publicado: (2020)

Anastrozole: Deep vein thrombosis and pulmonary embolism: case report
Publicado: (2021)

Tozinameran: Deep vein thrombosis and pulmonary embolism: case report
Publicado: (2021)

Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations
por: Winiarska, Aleksandra, et al.
Publicado: (2019)

Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation
por: Matusik, Paweł T., et al.
Publicado: (2019)

Chronic Kidney Disease and Its Impact on a Prothrombotic State in Patients with Atrial Fibrillation
por: Matusik, Paweł T., et al.
Publicado: (2020)

Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention
por: Yip, James, et al.
Publicado: (2016)

Deep vein thrombosis and pulmonary embolism – Prevention, management, and anaesthetic considerations
por: Narani, Krishan Kumar
Publicado: (2010)

Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolism
por: Ogbonna, Kelechi C, et al.
Publicado: (2015)

Pulmonary embolism and deep vein thrombosis related to oral contraceptive use
por: Kim, Ji-Yeong, et al.
Publicado: (2013)

Pulmonary Embolism and Coexisting Deep Vein Thrombosis: A Detrimental Association?
por: Cordeanu, Elena-Mihaela, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nenn55o6l02kr2joprkfsj6cf9